Amalgamated Financial’s Quest Diagnostics DGX Stock Holding History

Amalgamated Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$4.49M	Buy	+32,835	New	+$4.58M	0.04%	525

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Amalgamated Financial's DGX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Quest Diagnostics (DGX) in Q1 2022: 32,835 shares worth $4.49M. The stake represents 0.04% of the portfolio and ranks #525 among its holdings.

852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

Amalgamated Financial held 32,835 shares of Quest Diagnostics worth $4.49M as of Q1 2022.
Quest Diagnostics was a new Amalgamated Financial position in Q1 2022.
Quest Diagnostics made up 0.04% of Amalgamated Financial's portfolio in Q1 2022, its #525 holding.
852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.